AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
VENLAFAXINE HYDROCHLORIDE
9 registrations across 2 African markets— 9 active
Markets with VENLAFAXINE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| EFTRO 75 CAPSULE; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| LAFEKS 150 CAPSULE | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Dec 2027 |
| LAFEKS 37.5 CAPSULE | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Dec 2027 |
| LAFEKS 75 CAPSULE | 🇿🇼Zimbabwe | INNOVATA PHARMACEUTICALS | active | Dec 2027 |
| EFTRO 150 CAPSULE; ORAL | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Dec 2027 |
| EFTRO 150 CAPSULES | 🇬🇭Ghana | — | active | Jul 2027 |
| EFTRO 150 CAPSULES | 🇬🇭Ghana | — | active | Jul 2027 |
| EFTRO 75mg CAPSULES (Each hard gelatin capsule contains; Venlafaxine hydrochloride 75mg) | 🇬🇭Ghana | — | active | Jul 2027 |
| EFTRO 75mg CAPSULES (Each hard gelatin capsule contains; Venlafaxine hydrochloride 75mg) | 🇬🇭Ghana | — | active | Jul 2027 |
VENLAFAXINE HYDROCHLORIDE in Africa — Regulatory Overview
VENLAFAXINE HYDROCHLORIDE is registered across 2 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zimbabwe, Ghana. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.